Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
August 19, 2021
One-tissue compartment model for myocardial perfusion quantification with N-13 ammonia PET provides matching results: A cross-comparison between Carimas, FlowQuant, and PMOD
Sergey V Nesterov, Roberto Sciagrà, Luis Eduardo Juarez Orozco, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2025
MHC-I-Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy
Julie Constanzo, Aliasghar Parach, Timothee David, et al.
BMC Cancer
|
June 21, 2020
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases
Emmanuel Deshayes, Lauranne Piron, Antoine Bouvier, et al.
Antioxidants & Redox Signaling
|
May 26, 2016
Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted Effects
Salomé Paillas, Riad Ladjohounlou, Catherine Lozza, et al.
Annals of Nuclear Medicine
|
February 22, 2022
Myocardial perfusion quantification with Rb-82 PET: good interobserver agreement of Carimas software on global, regional, and segmental levels
Sergey V Nesterov, Emmanuel Deshayes, Luis Eduardo Juarez-Orozco, et al.
Antibodies (Basel, Switzerland)
|
October 24, 2025
Generation Using Phage-Display of pH-Dependent Antibodies Against the Tumor-Associated Antigen AXL
Tristan Mangeat, Célestine Mairaville, Myriam Chentouf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 21, 2018
Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer
Emmanuel Deshayes, Riad Ladjohounlou, Pierre Le Fur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2019
Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy
Riad Ladjohounlou, Catherine Lozza, Alexandre Pichard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 22, 2025
Rethinking Dosimetry: A European Perspective
Johannes Tran-Gia, Francesco Cicone, Michel Koole, et al.
Oncotarget
|
April 22, 2017
The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells
Pauline Estupina, Alexandre Fontayne, Jean-Marc Barret, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
August 19, 2021
One-tissue compartment model for myocardial perfusion quantification with N-13 ammonia PET provides matching results: A cross-comparison between Carimas, FlowQuant, and PMOD
Sergey V Nesterov, Roberto Sciagrà, Luis Eduardo Juarez Orozco, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2025
MHC-I-Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy
Julie Constanzo, Aliasghar Parach, Timothee David, et al.
BMC Cancer
|
June 21, 2020
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases
Emmanuel Deshayes, Lauranne Piron, Antoine Bouvier, et al.
Antioxidants & Redox Signaling
|
May 26, 2016
Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted Effects
Salomé Paillas, Riad Ladjohounlou, Catherine Lozza, et al.
Annals of Nuclear Medicine
|
February 22, 2022
Myocardial perfusion quantification with Rb-82 PET: good interobserver agreement of Carimas software on global, regional, and segmental levels
Sergey V Nesterov, Emmanuel Deshayes, Luis Eduardo Juarez-Orozco, et al.
Antibodies (Basel, Switzerland)
|
October 24, 2025
Generation Using Phage-Display of pH-Dependent Antibodies Against the Tumor-Associated Antigen AXL
Tristan Mangeat, Célestine Mairaville, Myriam Chentouf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 21, 2018
Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer
Emmanuel Deshayes, Riad Ladjohounlou, Pierre Le Fur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2019
Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy
Riad Ladjohounlou, Catherine Lozza, Alexandre Pichard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 22, 2025
Rethinking Dosimetry: A European Perspective
Johannes Tran-Gia, Francesco Cicone, Michel Koole, et al.
Oncotarget
|
April 22, 2017
The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells
Pauline Estupina, Alexandre Fontayne, Jean-Marc Barret, et al.
Page
of 8